The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMpactMF, randomized, open-label, phase 3 trial of imetelstat (IME) versus best available therapy (BAT) in patients (pts) with intermediate-2 (INT-2) or high-risk (HR) myelofibrosis (MF) relapsed or refractory (R/R) to Janus kinase inhibitors (JAKi).
 
John Mascarenhas
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Disc Medicine; Galecto; Geron; GlaxoSmithKline; Incyte; Kartos Therapeutics; Karyopharm Therapeutics; Keros Therapeutics; Merck; MorphoSys; MorphoSys; Novartis; Pharmaessentia; Roche/Genentech; SOBI; Sumitomo Pharma Oncology
Research Funding - Abbvie (Inst); Celgene/Bristol-Myers Squibb (Inst); Disc Medicine; Geron (Inst); Incyte (Inst); Kartos Therapeutics (Inst); MorphoSys; Novartis (Inst); Pharmaessentia (Inst); SOBI
 
Claire Harrison
Honoraria - Abbvie; CTI BioPharma Corp; Geron; GlaxoSmithKline (Inst); Janssen; Novartis
Consulting or Advisory Role - AOP Orphan Pharmaceuticals; BMS; Constellation Pharmaceuticals; CTI; Galecto; Geron; Incyte; Janssen; Keros Therapeutics; MorphoSys; Novartis; Roche
Speakers' Bureau - Abbvie; Bristol-Myers Squibb; CTI BioPharma Corp; Geron; GlaxoSmithKline; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Constellation Pharmaceuticals (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Prithviraj Bose
Honoraria - Abbvie; Blueprint Medicines; BMS; Cogent Biosciences; CTI BioPharma Corp; GlaxoSmithKline; Incyte; Ionis Pharmaceuticals; Jubilant Therapeutics; Karyopharm Therapeutics; Morphic Therapeutic; MorphoSys; Novartis; Pharmaessentia
Consulting or Advisory Role - Ono Pharmaceutical; Sierra Oncology
Research Funding - Blueprint Medicines (Inst); Bristol Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Cogent Biosciences (Inst); Constellation Pharmaceuticals (Inst); CTI BioPharma Corp (Inst); Geron (Inst); Incyte (Inst); Ionis Pharmaceuticals (Inst); Janssen (Inst); Kartos Therapeutics (Inst); Karyopharm Therapeutics (Inst); MorphoSys (Inst); Telios (Inst)
 
Jean-Jacques Kiladjian
Consulting or Advisory Role - Abbvie; AOP Orphan Pharmaceuticals; BMS; GlaxoSmithKline; Incyte; Novartis; Pharmaessentia
Travel, Accommodations, Expenses - Novartis
 
Alessandro Lucchesi
Consulting or Advisory Role - Aopsys; Morpho; Novartis; Protagonist Therapeutics; Sanofi; SOBI
Speakers' Bureau - Bristol-Myers Squibb; Incyte; Novartis; Pfizer; Sanofi; SOBI
 
Alessandro Vannucchi
Honoraria - Abbvie; AOP Orphan Pharmaceuticals; GlaxoSmithKline; Italfarmaco; Menarini; Novartis Italy
Consulting or Advisory Role - Italfarmaco
Research Funding - iOnctura (Inst)
 
Michelle Mudge-Riley
No Relationships to Disclose
 
Jennifer Riggs
Employment - Geron
Stock and Other Ownership Interests - Geron
 
Lixian Peng
Employment - Geron
Stock and Other Ownership Interests - Geron
 
Fei Huang
Employment - Geron
Stock and Other Ownership Interests - Bristol-Myers Squibb; Geron; Johnson & Johnson
 
Ying Wan
Employment - Geron
Stock and Other Ownership Interests - Geron
 
Vivian Rodolf
Employment - Geron
Stock and Other Ownership Interests - Geron
 
Judy Ho
Employment - Geron
Stock and Other Ownership Interests - Geron
 
Shyamala Navada
Employment - Geron
Stock and Other Ownership Interests - Geron
 
Rami Komrokji
Stock and Other Ownership Interests - Abbvie
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; DSI; Genentech; Geron; Janssen; Jazz Pharmaceuticals; Pharmaessentia; Rigel; Servio; SOBI; Sumitomo Pharma Oncology
Speakers' Bureau - Jazz Pharmaceuticals; Pharmaessentia; Rigel; SERVIER; SOBI
Research Funding - Bristol-Myers Squibb/Celgene (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Jazz Pharmaceuticals; Pharmaessentia